The Retinoblastoma Gene (RB-1) Status in Multiple Myeloma: A Report on 35 Cases

References

• Dewald G.W., Jenkins R.B. Cytogenetic and molecular genetic studies of patients with monoclonal gammapathies. Neoplastic Diseases of the Blood. Churchill Livingstone Inc, New York 1991; 427–438
   Google Scholar
• Facon T., Lai J.L., Trillot N., Flactif M., Zandecki M., Bauters F. Cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in patients with multiple myeloma: a report on 100 patients. Blood 1993a; 82: 1028a, suppl. 1
   Google Scholar
• Facon T., Lai J.L., Nataf E., Preudhomme C., Zandecki M., Hammad M., Wattel E., Jouet J.P., Bauters F. Improved cytogenetic analysis of bone marrow plasma cells after cytokine stimulation in multiple myeloma: a report on 46 patients. Br. J. Haematol. 1993b; 84: 743–745
   PubMed Web of Science ®Google Scholar
• Corradini P., Ladetto M., Voena C., Palumbo A., Inghirami G., Knowles D.M., Boccadoro M., Pileri A. Mutational activation of N- and K-ras oncogenes in plasma cell dyscrasias. Blood 1993; 81: 2708–2713
   PubMed Web of Science ®Google Scholar
• Preudhomme C., Facon T., Zandecki M., Vanrumbeke M., Lai J.L., Nataf Loucheux- E., Lefebvre M.H., Kerckaert J.P., Fenaux P. Rare occurrence of P53 gene mutations in multiple myeloma. Br. J. Haematol. 1992; 91: 440–443
   Web of Science ®Google Scholar
• Durie B.G.M. Cellular and molecular genetic factors of myeloma and related disorders. Hematology/Oncology Clinics of North America. W. B. Saunders Company, Harcourt Brace Jovanovich Inc., Philadelphia 1992; 463–477
   Google Scholar
• Dryja T.P., Rapaport J.M., Joyce J.M., Petersen A. Molecular detection of deletions involving band q 14 of chromosome 13 in retinoblastomas. Proc. Natl. Acad. Sci. 1986; 83: 7391–94
   PubMed Web of Science ®Google Scholar
• Friends S.H., Bernards R., Rogelj S. A human DNA segment with properties of the gene that predisposes to retinohlastoma and osteosarcoma. Nature 1986; 323: 643–646
   PubMed Web of Science ®Google Scholar
• Canning S., Dryja T.P. Short, direct repeats at the breakpoints of deletions of the retinoblastoma gene. Proc. Natl. Acad. Sci. 1989; 86: 5044–48
   PubMed Web of Science ®Google Scholar
• Yandell D.W., Se D., Campbell T.A. Oncogenic point mutation in the human retinoblastoma gene: their application to genetic counseling. N. Engl. J. Med. 1989; 321: 1689–95
   PubMed Web of Science ®Google Scholar
• Hensel H., Hsieh C.L., Gazdar A.F., Johnson B.E. Altered structure and expression of the human retinoblastoma susceptibility gene in small cell lung cancer. Cancer Res. 1990; 50: 3067–72
   PubMed Web of Science ®Google Scholar
• Reissmann P.T., Simon M.A., Lee W.H., Slamon D.J. Studies of the retinoblastoma gene in human sarcomas. Oncogene 1989; 4: 839–843
   PubMed Web of Science ®Google Scholar
• Mori N., Yokota J., Akiyama T., Semeshima Y. Variable mutations of the RB-1 gene in small cell lung carcinoma. Oncogene. 1990; 5: 1713–17
   PubMed Web of Science ®Google Scholar
• Cobrinik D., Dowdy S.F., Hinds P.W. The retinoblastoma protein and the regulation of cell cycling. TIBS 1992; 8: 312–315
   Google Scholar
• Furukawa Y., De Caprio J., Freedman A., Kanakura Y., Nakamura M., Ernst T.J., Livinston D.M., Griffin J.D. Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and non-cycling human hematopoietic cells. Proc. Natl. Acad. Sci. 1990; 87: 2770–74
   PubMed Web of Science ®Google Scholar
• Ahuja H.G., Jat P.S., Foti A., Bar-Eli M., Cline M.S. Abnormalities of the retinoblastoma gene in pathogenesis of acute leukemia. Blood 1991; 78: 3259–68
   PubMed Web of Science ®Google Scholar
• Cheng J., Scully P., Shew J.Y., Lee V.H., Vila V., Haas M. Homozygous deletion of the retinoblastoma gene in an acute lymphoblastic leukemia (T) cell line. Blood 1990; 75: 730–35
   PubMed Web of Science ®Google Scholar
• Towatari M., Adachi K., Kato H., Saito H. Absence of the human retinoblastoma gene product in the megacaryoblastic crisis of chronic myelogenous leukemia. Blood 1991; 78: 2178–81
   PubMed Web of Science ®Google Scholar
• Preudhomme C., Vachee A., Lepelley P., Vanrumbeke M., Zandecki M., Quesnel B., Cosson A., Fenaux P. Inactivation of the retinoblastoma gene appears to he very uncommon in myelodysplastic syndromes. Br. J. Haematol. 1994; 87: 61–67
   PubMed Web of Science ®Google Scholar
• Tang J.L., Yeh S.H., Chen P.J., Lin M.T., Tien H.F., Chang Y. Inactivation of the retinoblastoma gene in acute myelogenous leukemia. Brit. J. Haematol. 1992; 82: 502–507
   PubMed Web of Science ®Google Scholar
• Weide R., Parviz B., Pfluger K.H., Havemann K. Altered expression of the human retionoblastoma gene in monocytic leukemias. Brit. J. Haematol. 1993; 83: 428–432
   PubMed Web of Science ®Google Scholar
• Juliusson G., Oscier D.G., Fitchett M., et al. Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. N. Engl. J. Med. 1990; 323: 720
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S., Dohner H., Bulgay-Morschel M., Weitz S., Bentz M., Lichter P. High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood 1993; 81: 2118–2124
   PubMed Web of Science ®Google Scholar
• Kay N.E., Suen R., Ranheim E., Peterson L.C. Conformation of RB-1 gene defects in B-CLL clones and evidence for variable predominance of the RB-1 defective cells within the CLL clone. Brit. J. Haematol. 1993; 84: 257–264
   PubMed Web of Science ®Google Scholar
• Orita M., Suzuki Y., Sekuja T., Hayashi K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the PCR. Genomics 1989; 5: 874
   PubMed Web of Science ®Google Scholar
• Hogg A., Onadim Z., Baird P.N., Cowel J.L. Detection of heterozygous mutations in the RB-1 gene in retinoblastoma patients using single-strand conformation polymorphism analysis and polymerase chain reaction sequencing. Oncogene 1992; 7: 1445–51
   PubMed Web of Science ®Google Scholar
• Durie B.G.M., Salmon S.E. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment and survival. Cancer 1975; 36: 842–854
   PubMed Web of Science ®Google Scholar
• Harris C.C., Hollstein M. Clinical implications of the p53 tumor-suppressor gene. N. Engl. J. Med. 1993; 329: 1318–1327
   PubMed Web of Science ®Google Scholar
• Fenaux P., Jonveaux P., Quiquandon I, et al. P53 gene mutations in acute myeloid leukemia with 17p monosomy. Blood 1991; 78: 1652–57
   PubMed Web of Science ®Google Scholar
• De Caprio J.A., Ludlow J.W., Figge J. SV 40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54: 275–281
   PubMed Web of Science ®Google Scholar
• Brown A.G., Fiona M.R., Eimear M.D., Steel C.M., Weir-Thompson E.M. Evidence for a new tumor suppressor locus (DBM) in human B-cell neoplasia telomeric to the retinoblastoma gene. Nature Genet. 1993; 3: 67
   PubMed Web of Science ®Google Scholar
• Chapman R.M., Corcoran M.M., Gardiner A., Hawthorn L.A., Cowell J.K., Oscier D.G. Frequent homozygous deletions of the D13S25 locus in chromosome region 13q 14 defines the location of a gene critical in leukaemogenesis in chronic B-cell lymphocytic leukaemia. Oncogene 1994; 9: 1289–1293
   PubMed Web of Science ®Google Scholar